FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:2152-2153 November 18, 2004 Number 21 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Dave, S. S. PubMed Citation

Considerable clinical heterogeneity and wide variation in survival among patients are characteristic of many B-cell lymphomas. Prognostic markers that predict the clinical behavior of such tumors with greater accuracy than is currently possible are urgently needed to permit management decisions based on the prognosis in individual cases. Moreover, the variable course of some types of B-cell lymphomas may indicate that they are actually a mixture of distinct cancers that are not distinguished by the current classification schemes. In recent years, several large-scale studies involving microarray-based gene-expression profiling have identified novel lymphoma subtypes and improved the accuracy of predictions of outcome. . . . [Full Text of this Article]

Source Information

From the Institute for Cell Biology (Tumor Research), University of Duisburg–Essen Medical School, Essen, Germany.

This article has been cited by other articles:

• Cerhan, J. R., Wang, S., Maurer, M. J., Ansell, S. M., Geyer, S. M., Cozen, W., Morton, L. M., Davis, S., Severson, R. K., Rothman, N., Lynch, C. F., Wacholder, S., Chanock, S. J., Habermann, T. M., Hartge, P. (2007). Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood 109: 5439-5446 [Abstract] [Full Text]  
• Hilchey, S. P., De, A., Rimsza, L. M., Bankert, R. B., Bernstein, S. H. (2007). Follicular Lymphoma Intratumoral CD4+CD25+GITR+ Regulatory T Cells Potently Suppress CD3/CD28-Costimulated Autologous and Allogeneic CD8+CD25- and CD4+CD25- T Cells. J. Immunol. 178: 4051-4061 [Abstract] [Full Text]  
• Alvaro, T., Lejeune, M., Salvado, M.-T., Lopez, C., Jaen, J., Bosch, R., Pons, L. E. (2006). Immunohistochemical Patterns of Reactive Microenvironment Are Associated With Clinicobiologic Behavior in Follicular Lymphoma Patients. JCO 24: 5350-5357 [Abstract] [Full Text]  
• de Jong, D. (2005). Molecular Pathogenesis of Follicular Lymphoma: A Cross Talk of Genetic and Immunologic Factors. JCO 23: 6358-6363 [Abstract] [Full Text]